Study Evaluating the Efficacy and Safety of RAP-219 in Adult Participants With Focal Seizures FOCUS-1
for Focal Seizure
3 locations incl. Palmdale
Sponsor: Rapport Therapeutics Inc.
Sex: All·Age: 18 - 75
Code: NCT07563881·Phase 3·Recruiting·Listed May 2026